Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gergis, Mark
100  Ergebnisse:
Personensuche X
?
1

Drivable Area Segmentation in Deteriorating Road Regions fo..:

, In: 2021 IEEE Intelligent Vehicles Symposium (IV),
Ali, Abdelrahman ; Gergis, Mark ; Abdennadher, Slim. - p. 845-852 , 2021
Link: https://doi.org/10.1109/..
 
?
2

ROS-based Model Predictive Trajectory Tracking Control Arch..:

, In: 2019 IEEE Intelligent Transportation Systems Conference (ITSC),
Guirguis, Silvana ; Gergis, Mark ; Elias, Catherine M... - p. 2750-2756 , 2019
Link: https://doi.org/10.1109/..
 
?
3

Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (..:

Patel, Krina K. ; Rodríguez-Otero, Paula ; Nooka, Ajay K....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S322 , 2024
Link: https://doi.org/10.1016/..
 
?
4

P-008 Idecabtagene vicleucel (ide-cel) vs standard regimens..:

Einsele, Hermann ; Rodriguez-Otero, Paula ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S37 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS..:

Manier, Salomon ; Rodríguez-Otero, Paula ; Mateos, Maria-Victoria...
HemaSphere.  7 (2023)  S3 - p. e3385948 , 2023
Link: https://doi.org/10.1097/..
 
?
6

A simple prognostic system in patients with myelofibrosis u..:

Tamari, Roni ; McLornan, Donal P. ; Ahn, Kwang Woo...
Blood Advances.  7 (2023)  15 - p. 3993-4002 , 2023
Link: https://doi.org/10.1182/..
 
?
7

P-031 Idecabtagene vicleucel (ide-cel) vs standard regimens..:

Manier, Salomon ; Rodriguez-Otero, Paula ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S50-S51 , 2023
Link: https://doi.org/10.1016/..
 
?
8

The mutational landscape in chronic myelomonocytic leukemia..:

Mei, Matthew ; Pillai, Raju ; Kim, Soyoung...
Haematologica.  108 (2022)  1 - p. 150-160 , 2022
Link: https://doi.org/10.3324/..
 
?
9

A Personalized Prediction Model for Outcomes after Allogene..:

Nazha, Aziz ; Hu, Zhen-Huan ; Wang, Tao...
Biology of Blood and Marrow Transplantation.  26 (2020)  11 - p. 2139-2146 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Comparison of outcomes of HCT in blast phase of BCR-ABL1− M..:

Gupta, Vikas ; Kim, Soyoung ; Hu, Zhen-Huan...
Blood Advances.  4 (2020)  19 - p. 4748-4757 , 2020
Link: https://doi.org/10.1182/..
 
?
11

High-dose bendamustine and melphalan conditioning for autol..:

Gomez-Arteaga, Alexandra ; Mark, Tomer M. ; Guarneri, Danielle...
Bone Marrow Transplantation.  54 (2019)  12 - p. 2027-2038 , 2019
Link: https://doi.org/10.1038/..
 
?
12

Granulocyte Colony-Stimulating Factor Use after Autologous ..:

Singh, Amrita D. ; Parmar, Sapna ; Patel, Khilna...
Biology of Blood and Marrow Transplantation.  24 (2018)  2 - p. 288-293 , 2018
Link: https://doi.org/10.1016/..
 
?
13

A Pilot Study of a Sequential Regimen of Intensive Chemothe..:

Shore, Tsiporah B. ; Jhanwar, Yuliya ; Baldo, Maria...
Biology of Blood and Marrow Transplantation.  23 (2017)  3 - p. S272 , 2017
Link: https://doi.org/10.1016/..
 
?
14

A global multiproxy database for temperature reconstruction..:

PAGES2k Consortium ; Emile-Geay, Julien ; McKay, Nicholas P....
Scientific Data.  4 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
15

A Phase I Trial of High-Dose Lenalidomide and Melphalan as ..:

Mark, Tomer M. ; Guarneri, Danielle ; Forsberg, Peter...
Biology of Blood and Marrow Transplantation.  23 (2017)  6 - p. 930-937 , 2017
Link: https://doi.org/10.1016/..
 
1-15